BNC210
 | |
| Systematic (IUPAC) name | |
|---|---|
|
L-Isoleucyl-L-tryptophan | |
| Clinical data | |
| Legal status |
|
| Identifiers | |
| ATC code | none |
| PubChem | CID 7019084 |
| ChemSpider | 5382052 |
| Chemical data | |
| Formula | C17H23N3O3 |
| Molar mass | 317.39 g·mol−1 |
| |
| |
BNC210 (also known as IW-4123 during its time licensed to Ironwood Pharmaceuticals) is an anxiolytic drug that acts via negative allosteric modulation of the α7-nicotinic acetylcholine receptor,[1] by Bionomics Limited. It demonstrates clinically significant anxiety reduction in both animal models and in Phase I trials.[2]
It appears to be devoid of significant sedation or memory-impairing side effects, as well as lacking addictive potential in rat discriminatory models.[3]
Phase I trials have shown no serious side effects.
Bionomics previously licensed it to Ironwood Pharmaceuticals in January 2012, where it was known as IW-2143. In December 2012, IW-2143 begun undergoing phase I clinical trials in the United States,[4] but in November 2014, was released back to Bionomics in a mutual agreement.[5] Bionomics will now continue development and clinical testing, with Ironwood receiving a royalty for their work done.
As of April 2015, BNC210 is in phase II clinical trials.[6]
See also
References
- ↑ http://www.bionomics.com.au/upload/investors/asx-announcements/4736/ASX695%20%20BNC210%20Phase%201b%20initiation.pdf
- ↑ "Bionomics - Pipeline". Retrieved 2010-11-09.
Bionomics has discovered a novel compound, BNC210, that offers dramatic competitive advantages over existing treatments
- ↑ O'Connor, S.; Andriambeloson, E.; Huyard, B.; Wagner, S.; Sleebs, B.; Quasi, N.; Bui, C.; Street, I. "BNC210: A Novel Compound with Potent Anxiolytic Activity" (PDF). Bionomics Limited. Retrieved 2010-11-09.
By applying a targeted medicinal chemistry strategy beginning from a compound cited in the literature, Bionomics has developed BNC210
- ↑ http://investor.ironwoodpharma.com/releasedetail.cfm?ReleaseID=733540
- ↑ http://www.biotechdaily.com.au/media/backissues/2014/11%20Nov/BD%20Biotech%20Daily%20Nov%2011.pdf
- ↑ Bionomics Limited. "www.prnewswire.com" (HTML). PRNewswire. Retrieved 2015-06-10.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.